Angela Beltran
Nurse Practitioner · Sun City West, AZNPI 1922792795
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 657 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 13.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $6,177, 3.7 times the $1,652 reported in 2023. Among nurse practitioner clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 657 payments — averaging $18.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$2K
- AbbVie$1K
- AstraZeneca$1K
- Biogen$699
- Lilly USA, LLC$632
- Amneal Pharmaceuticals LLC$609
- plus $6K from 33 others
What the payments were for
- Food & beverage$11,71999%
- Education$1461%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 132 | $1,643 |
| AbbVie | 80 | $1,209 |
| AstraZeneca(2 entities) | 24 | $1,075 |
| Biogen | 46 | $699 |
| Lilly USA, LLC | 29 | $632 |
| Amneal Pharmaceuticals LLC | 60 | $609 |
| Teva Pharmaceuticals USA, Inc. | 35 | $603 |
| SK Life Science, Inc. | 18 | $552 |
| Pfizer | 30 | $522 |
| Eisai Inc. | 25 | $511 |
| Genentech USA, Inc. | 22 | $505 |
| Novartis | 28 | $462 |
| Sanofi | 7 | $435 |
| Argenx US, Inc. | 12 | $337 |
| Acadia Pharmaceuticals Inc | 16 | $270 |
| Otsuka America Pharmaceutical, Inc. | 6 | $234 |
| EMD Serono, Inc. | 4 | $174 |
| Grifols USA, LLC | 6 | $166 |
| Bristol Myers Squibb | 14 | $162 |
| Impel Pharmaceuticals Inc. | 14 | $145 |
| Lundbeck LLC | 9 | $141 |
| Banner Life Sciences, LLC | 6 | $108 |
| Impel Pharmaceuticals LLC | 4 | $85 |
| Neurelis, Inc. | 4 | $73 |
| Amgen | 3 | $73 |
| Tonix Medicines, Inc. | 3 | $60 |
| Neurocrine Biosciences, Inc. | 3 | $54 |
| Axsome Therapeutics, Inc. | 2 | $51 |
| Mallinckrodt Hospital Products Inc. | 2 | $35 |
| Scilex Pharmaceuticals Inc. | 2 | $35 |
| GE HealthCare | 1 | $35 |
| Corium, LLC | 3 | $28 |
| Noctrix Health, Inc. | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Cycle Pharmaceuticals Inc | 1 | $24 |
| Johnson & Johnson | 1 | $20 |
| C2n Diagnostics, LLC | 1 | $18 |
| Kyowa Kirin, Inc. | 1 | $14 |
| Vanda Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,865 in reported general payments places this provider in the 95th percentile of 1,719 nurse practitioner providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| QuliptaAtogepant | 14 | $18,568 |
| Emgality PenGalcanezumab-Gnlm | 20 | $15,679 |
| UbrelvyUbrogepant | 15 | $13,783 |
| Ajovy AutoinjectorFremanezumab-Vfrm | 11 | $12,157 |
| Lacosamide | 33 | $5,294 |
| Gabapentin | 256 | $4,256 |
| Pregabalin | 135 | $3,553 |
| Memantine Hcl | 141 | $3,182 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 52 | $2,768 |
| Levetiracetam | 57 | $2,165 |
| Galantamine Hbr | 16 | $1,443 |
| Duloxetine Hcl | 54 | $1,407 |
| Donepezil Hcl | 145 | $1,398 |
| Sumatriptan Succinate | 28 | $1,375 |
| Tizanidine Hcl | 19 | $1,061 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieQulipta, Ubrelvy | $1,209 | $32,35129 claims |
| Amneal Pharmaceuticals LLCPyridostigmine Bromide | $609 | $36812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,719 nurse practitioner providers in Arizona.
Other nurse practitioner in Sun City West
- Ann MooreGlendale$208K
- Sandra KurtinTucson$201K
- Kristen HerzogScottsdale$162K
- Krista ArredondoChandler$133K
- Shannon MorgensternOro Valley$71K
- Helena In't VeldPhoenix$64K
- Steven KalfusChandler$43K
- Dustin NickersonPhoenix$39K
- Shannon BoffeliFlagstaff$31K
- Kelley RoneScottsdale$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.